Elevated alpha-fetoprotein and a normal fetal sonogram: association with placental abnormalities.
This report documents the outcome of 25 pregnancies with elevated serum alpha-fetoprotein levels on two separate samplings despite normal anatomic appearance of the fetus on a detailed "consultative" sonographic examination. Six of these also had elevated amniotic fluid alpha-fetoprotein. All fetuses in this series were anatomically normal at time of delivery; one aborted fetus was triploid. Of the 25 pregnancies, 16 had sonographically demonstrable placental hemorrhage, eight retroplacental and eight subchorionic. One had hydropic changes in the placenta associated with triploidy. Of the subgroup of six pregnancies in which both serum and amniotic fluid values were elevated, one had a retroplacental hemorrhage, one had a subchorionic hemorrhage, and one had diffuse hydropic changes in the placenta. A control group of 112 patients with normal alpha-fetoprotein levels yielded four with small (less than 2 cm3) subchorionic hemorrhage. The occurrence rate of placental hemorrhage in women with elevated alpha-fetoprotein and normal fetus was 64%, whereas the control group of patients with normal alpha-fetoprotein had a 3.6% occurrence rate of placental hemorrhage. Sonographically detectable placental abnormalities may be associated with elevated alpha-fetoprotein in serum and/or amniotic fluid samples. Such abnormalities may occur because of fetomaternal admixture associated with placental hemorrhage and/or intraamniotic bleeding resulting from subchorionic hemorrhage.
D000653:Amniotic Fluid / Q000378:metabolism; D005260:Female; D005333:Fetus / Q000033:anatomy & histology*; D006470:Hemorrhage / Q000175:diagnosis* / Q000378:metabolism; D006801:Humans; D010922:Placenta Diseases / Q000175:diagnosis* / Q000378:metabolism; D011247:Pregnancy; D012189:Retrospective Studies; D014463:Ultrasonography; D000509:alpha-Fetoproteins / Q000378:metabolism*
D000509:alpha-Fetoproteins